Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30125% above fair value
$7.65−0.12 (-1.54%)
Close on Nov 17, 2026Market cap $410.72MP/E –Yield –
Alpha Teknova market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Alpha Teknova's market cap was $462.74M on Nov 11, 2026, against $250.49M a year earlier. Over the last 5 years it ranged from $53.26M to $573.68M, with a median of $202.12M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $462.74M | +127.5% |
| 2025 | Dec 31, 2025 | $203.39M | -54.3% |
| 2024 | Dec 31, 2024 | $445.08M | +193.0% |
| 2023 | Dec 29, 2023 | $151.91M | -4.2% |
| 2022 | Dec 30, 2022 | $158.66M | -72.3% |
| 2021 | Dec 31, 2021 | $573.68M | – |
See a number that looks wrong?